Subsense, the maker of brain-computer interfaces (BCI) to treat neurodegenerative diseases, raised $10 million in additional seed funding, CEO Tetiana Aleksandrova tells Axios Pro exclusively.
What's next: Subsense plans to begin raising a $100 million Series A round in January, she says.
